My NCBISign In

Display Settings:

Format

Send to:

Choose Destination
    Prog Cardiovasc Dis. 2005 Sep-Oct;48(2):139-45.

    Selection of drugs in pursuit of a rhythm control strategy.

    Kowey PR, Stoenescu ML.

    Source

    Department of Cardiology, Lankenau Hospital, MOBE Suite 558, 100 Lancaster Avenue, Wynnewood, PA 19096, USA. koweypr@mlhheart.org

    Abstract

    A rhythm control strategy based on a combination of antiarrhythmic drugs and electrical cardioversion(s) has emerged as a viable alternative for treatment of atrial fibrillation, particularly when the arrhythmia is associated with symptoms, which may be poorly tolerated, or with congestive heart failure. Several classes of antiarrhythmic drugs are available to restore sinus rhythm by chemical cardioversion and to help maintain it once it has been achieved. In our discussion, we will detail aspects of their efficacy and safety, and attempt to outline a pragmatic clinical approach to their use. Some newer drugs are currently under investigation and hold promise for improved efficacy and/or more favorable side effect profile and will be mentioned in this article.

    PMID:
    16253653
    [PubMed - indexed for MEDLINE]

    MeSH Terms, Substances

    MeSH Terms

    Substances

    LinkOut - more resources

    Full Text Sources

    Other Literature Sources

      Supplemental Content

      Click here to read

      Related citations

      See reviews... See all...

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk